Business Advisory Board

4 November, 2007

Dr. Johnson Lau

Dr. Johnson Lau has had a distinguished career in academic medicine and clinical research and has also held senior positions at major pharmaceutical companies in research and administrative divisions.  Dr. Lau led the public offering for Ribapharm, the second largest biotech offering to date after Genetech.  Dr. Lau also served as Managing Director for Roth Capital Partners in the healthcare area.  He currently consults for Governmental Agencies and the Healthcare and Investment Banking industries.

Dr. Kenji Kitatani

Dr. Kenji Kitatani was formerly a senior executive at Sony Corporation as well as having had major management assignments as President of the Tokyo Dome and other media and entertainment companies. He has taught, and continues to teach as a Distinguished Professor at the University level.  Dr. Kitatani is a consultant to many international companies and sits on the Board of Directors of one of the largest infomercial companies in Japan.  Dr. Kitatani is also currently involved with the entertainment industry and brings talent to venues in Asia.